TransMedics Group, Inc. — Director's Dealing 2020

Dec 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2020-12-11

Reporting Person: Provost Miriam (VP of US Regulatory & FDA Rel.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-11	Common Stock	M	4600	$3.22	Acquired	4600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (Right to Buy)	$3.22	M	4600	Disposed	2028-04-05	Common Stock (4600)	Direct

Footnotes

F1: The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and will vest at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date.